-
WY-14643 (Pirinixic Acid), a moderate dual PPARα/γ activator, inhibits neuroinflammation and oxidative stress, and also possesses antidepressive activities. WY-14643 (Pirinixic Acid)是一种有效的过氧化物酶体增殖子和PPARα激活剂，EC50为1.5 μM。
More
-
Entinostat (MS-27-275, MS-275, SNDX-275) an orally class I histone deacetylase (HDAC)-specific inhibitor, is currently in clinical trials.
More
-
Tamoxifen citrate, a selective non-steroidal estrogen receptor antagonist, was approved by FDA as a drug that is utilized in the treatment of estrogen receptor–positive breast cancer. Tamoxifen Citrate是一种雌激素受体拮抗剂，与雌激素竞争性结合。
More
-
Lapatinib Ditosylate is the xylenesulfonic acid salt form of lapatinib (GW-572016), a small-molecule dual inhibitor of EGFR and ErbB2 receptor kinase activities. Lapatinib ditosylate (甲苯磺酸拉帕替尼; GW-572016 ditosylate) 是EGFR和ErbB2抑制剂，IC50分别为10.8和9.2 nM。
More
-
(+)-JQ1, an active enantiomer of JQ1, is a potent, highly specific and Kac-competitive inhibitor of bromodomain and extraterminal domain (BET) proteins, blocks BRD4 resulting in inhibition of c-Myc expression and tumor growth. (+)-JQ1是一种BET bromodomain抑制剂，作用于BRD4(2)，IC50为33 nM，结合到BET家族的所有Bromodomain结构域，而不结合到BET家族以外的Bromodomain结构域。
More
